PMC:7755033 / 5248-5554
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"133","span":{"begin":239,"end":245},"obj":"Species"},{"id":"146","span":{"begin":190,"end":198},"obj":"Disease"},{"id":"147","span":{"begin":225,"end":233},"obj":"Disease"}],"attributes":[{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"Tax:9606"},{"id":"A146","pred":"tao:has_database_id","subj":"146","obj":"MESH:C000657245"},{"id":"A147","pred":"tao:has_database_id","subj":"147","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ll date, research has identified more than 30 therapeutic agents, including natural products, allopathic drugs and traditional Chinese medicines which could potentially be effective against COVID-19. For initial treatment of COVID-19, the People's Republic of China National Health Commission (NHC) has inc"}